Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 2,779,300 | 2,013,000 | 1,989,800 | 1,895,500 | 1,750,200 |
| Cost of Goods | 1,470,600 | 1,083,200 | 1,050,300 | 1,086,600 | 1,011,900 |
| Gross Profit | 1,308,700 | 929,800 | 939,500 | 808,900 | 738,300 |
| Operating Expenses | 1,377,300 | 779,500 | 107,900 | 852,100 | 725,600 |
| Operating Income | -68,000 | 150,500 | -463,100 | -42,600 | 13,600 |
| Interest Expense | 77,700 | 52,900 | 55,100 | 54,100 | 49,500 |
| Other Income | -1,100 | -700 | 5,000 | 21,400 | 153,100 |
| Pre-tax Income | -146,800 | 96,900 | -513,200 | -75,300 | 117,200 |
| Income Tax | 1,700 | 31,400 | 51,400 | 28,200 | 88,200 |
| Net Income Continuous | -148,500 | 65,500 | -564,600 | -103,500 | 29,000 |
| Minority Interests | -100 | -100 | 200 | -700 | N/A |
| Net Income | $-148,400 | $65,600 | $-564,800 | $-102,800 | $28,000 |
| EPS Basic Total Ops | -0.86 | 0.50 | -4.27 | -0.79 | 0.21 |
| EPS Basic Continuous Ops | -0.86 | 0.49 | -4.27 | -0.79 | 0.23 |
| EPS Diluted Total Ops | -0.86 | 0.49 | -4.27 | -0.79 | 0.22 |
| EPS Diluted Continuous Ops | -0.86 | 0.49 | -4.27 | -0.79 | 0.23 |
| EBITDA(a) | $552,800 | $347,400 | $1,035,000 | $258,600 | $280,400 |